The highly-anticipated Anderson Silva-Chael Sonnen rematch scheduled for UFC 148 this summer isn’t exactly a go just yet.
Next Monday, May 21, the Nevada State Athletic Commission will determine whether or not Sonnen will be granted a therapeutic use exemption for testosterone replacement therapy, allowing the fighter to supplement his hormone levels with synthetic testosterone. Though TRT is legal, an athlete must be determined as medically in need of the treatment to be on it during competition.
After Sonnen first challenged Silva for the title, at UFC 117 in 2010, Sonnen registered an elevated testosterone-to-epitestosterone ratio of 16.9:1 (well above California’s limit of 4:1) and was eventually suspended for that and for improperly disclosing his usage of TRT to the athletic commission.
If his request is granted, Sonnen will become only the fourth fighter to ever be granted a TUE for TRT by the Nevada State Athletic Commission.
Nick Diaz is also listed on the NSAC’s Monday docket, up last for his disciplinary hearing over testing positive for marijuana metabolites following his UFC 143 loss to Carlos Condit.